Navigation Links
Study: Modafinil is effective in treating excessive sleepiness
Date:10/15/2007

WESTCHESTER, Ill. A study published in the October 15 issue of the Journal of Clinical Sleep Medicine (JCSM) finds that modafinil is well-tolerated in the treatment of excessive sleepiness associated with disorders of sleep and wakefulness such as shift work sleep disorder, obstructive sleep apnea (OSA) and narcolepsy, and does not affect cardiovascular or sleep parameters.

The study, authored by Thomas Roth, PhD, of the Henry Ford Sleep Center in Detroit, Mich., focused on 1,529 outpatients who received modafinil 200, 300 or 400 mg, or a placebo once per day for up to 12 weeks. A total of 934 patients received modafinil, and 567 received a placebo. The subjects were assessed for adverse events and effects of modafinil on blood pressure/heart rate, electrocardiogram intervals, polysomnography, and clinical laboratory parameters.

According to the results, modafinil was well tolerated versus a placebo, with headache, nausea and infection the most common adverse side effect. The overall incidence of side effects was similar among the three modafinil dosage groups. Adverse events occurring more frequently in the modafinil group than in controls included headache, nausea, dry mouth, anorexia, nervousness, insomnia, anxiety, hypertension and pharyngitis. In patients taking modafinil, 19 serious adverse events occurred, while in the placebo group, there were 10 serious adverse events.

In modafinil-treated patients clinically significant increases in diastolic or systolic blood pressure were infrequent. In the narcolepsy studies one patient in the modafinil group and one in the placebo group had a clinically significant increase in heart rate.

New clinically meaningful electrocardiogram abnormalities were rare with the modafinil and placebo group.

Modafinil did not affect sleep architecture in any patient population according to polysomnography.

Clinically significant abnormalities in mean laboratory p
'/>"/>

Contact: Jim Arcuri
jarcuri@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Counter study: cholesterol drugs no good in preventing colon cancer
2. A strategic study: Soy diet makes heart disease to worsen in male mice
3. Bird Flu Pandemic Study: Clerical & Support Staff May Stay At Home
4. Study: Older Pancreatic Cancer Surgery Survivors Live Long
5. New Study: Pine Bark Significantly Reduces Endometriosis
6. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
7. Inhaled Steroids Safe & Effective for Children with Asthma
8. Morning after pill effective up to five days after having unprotected sex
9. Distraction therapy found very effective in postoperative patients
10. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
11. TELITHROMYCIN - the proven effective new drug for cap

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)..., Benton Communications a...iness growth system for retailers struggling to ma... (PRWEB) November 26, 2009 -- Flu fears is the ty...es to the emergency room, according to Dr. David B...wly released business growth system – The R...
(Date:11/25/2009)...,, TORONTOandCALGARY,Nov.25/PRNewswire/-Sent...sonanceImaging(MRI)coilsandsoftwareandCalgaryScien...logies,haveintroducedawebversionofAegis(TM)Breast4...veinterfaceisthefirsttrulyzero-footprintWebclientb...tific,sPureWeb(TM)platformallowsforzero-footprinta...
(Date:11/25/2009)...,, SANFRANCISCO,Nov.25/PRNewswire/--TheBayAr...first Winter Spare the Air Alert for...acturedfirelogsoranyothersolidfuel,bothindoorsando...nhealthyairqualitytomorrow,"saidJackBroadbent,exec...sidentstorespectthehealthoftheirneighborsandfellow...
(Date:11/25/2009)..., Does stress increase blood pressure? This simp... for many years. New Stress-related gene Modulate...increase blood pressure? This simple question has.... Now new research has for the first time establi...he blood pressure response to stress in mice as we...
(Date:11/25/2009)... Survivors often plagued by neurological symptoms,...althDay News) -- Neurological side effects are amo...vors of testicular cancer who were treated with ci... , The study included 1,409 Norwegian men treat...nd 1994 who took part in a follow-up survey conduc...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
...F PRUSSIA, Pa., Jan. 16 Universal,Health Services...d of,Directors voted to pay a cash dividend of $0....record as of March 3, 2008., Universal Health Ser...bulatory centers nationwide and in Puerto Rico., ...
...earchers at the Johns Hopkins Brady Urological Ins...Institute in Sweden have identified an array of ge...ong with family history for the disease, appear to...kers are common and could account for nearly half ...
...chers unclear on whether it,s reluctance to submi... , WEDNESDAY, Jan. 16 (HealthDay News) -- A sy...ludes that the positive effects of these drugs are...y journals not to publish them, or a combination ...
...e first time, researchers say targeting these unit..., Jan. 16 (HealthDay News) -- Melanoma has joined ...ulation of primordial cancer stem cells, Harvard r...umor. , "The findings validate for the first time ...
...pends Half-Million Annually to Provide "Critter Co...kangaroo,fifty-six dogs, forty-five cats, two mini...three guinea pigs and more than 400 fish and birds...caring for the pets that reside at its communities...
...ent Provides for Provider Services, Inc. to fund $...he Ready-To-Drink Product to be Developed by Mill...year Purchase Agreem...oard: MBTG) today announced that it will receive $...
Other Medicine News:Health News:Gene markers located for hereditary prostate cancer 2Health News:Gene markers located for hereditary prostate cancer 3Health News: Antidepressant Effectiveness Probably Overstated: Report 2Health News: Antidepressant Effectiveness Probably Overstated: Report 3Health News:Researchers Hone in on Cancer Stem Cells for Melanoma 2Health News:Researchers Hone in on Cancer Stem Cells for Melanoma 3Health News:500-Plus Animals Part of the Team at Healthcare Organization 2Health News:Millennium Enters Into $600,000 Product Development Agreement to Fund Product Development for the $20,000,000 Purchase Agreement with Provider Services, Inc. 2
(Date:11/25/2009)...ov.25/PRNewswire/--PraxisElectronicMedicalRecordsr...ilyPhysicians,(AAFP)FamilyPracticeManagement(FPM)2...lity,healthmaintenance,anddiseasemanagement,allcri...d#1amongdoctorsindicatingtheirEMRhadapositiveeffec...numberoneinthecountryinprovidingexcellenttraininga...
(Date:11/25/2009).../PRNewswire-FirstCall/--ERT(Nasdaq: ERES ),announc...entandCEO,andKeithSchneck,theCompany,sExecutiveVic...ualPiperJaffrayHealthCareConferenceat1:30PMESTonDe...dpartiesmayaccessthepresentationbyvisitingtheCompa...astmayalsobeaccessedat http://www.corporate-ir.net...
(Date:11/25/2009)....25/PRNewswire-USNewswire/--RemediumTechnologiesIn...psseverebleeding,wonfirstprizeand$10,000intheMostP...llenge2009,companyofficialsannouncetoday. ,, Se...edium,steampitchedtheirinventionattheGSCSecuritySu..., Remedium( www.remediumtechnologies.com )isdevel...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Psoriasis Raises Risk of Heart Attack Stroke Death 48954 1Psoriasis Raises Risk of Heart Attack Stroke Death 48954 2First Spine Technology Awards to Recognize Excellence and Innovation 48952 1First Spine Technology Awards to Recognize Excellence and Innovation 48952 2MUHC researcher awarded 24500 000 to study pathogenesis of infectious disease 48951 1MUHC researcher awarded 24500 000 to study pathogenesis of infectious disease 48951 2
...st-hoc analysis shows nearly nine out of ten patie... at the end of 12 months, WASHINGTON, D.C., May 22... III, open-label 12-14 month extension study (303)...ogy (BSG) meeting,in Glasgow, Scotland in March 20...olerated in mild to moderate UC,patients. Today, s...
...MIRA Data Showed 57 Percent Reduction in Risk of H... One Year, ABBOTT PARK, Ill., May 22, 2007 /PRNews...from a post-hoc analysis of a pivotal study,presen...n,Washington, D.C. showing patients with moderate ...MIRA(R) (adalimumab) maintenance,therapy were almo...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 2New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 3New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 4New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 5New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 6New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 7
...t alternative to Equalizers, the patented EXP Syst...tween two different vessel configurations. With th...ly and easily adjusted for test tubes (and microce...gn for Unparalleled Comfort Pick one of our pipet...
...bility The Equalizer 384 includes all the revolu...le and equal tip spacing, choice of two software p...ration capabilities. In addition, this model allow...loading and accessing many gels and for use with 3...
PrismPipette 96-lane Starter Set
BioPette E Electronic Multi-Channel Pipettor, 10-200l
Medicine Products: